일반명 약품
★ generic drug (법적 보호를 받는 등록된 상품명이 아닌) 일반명 약품
* The world's leading drugmakers face a growing threat from generic-drug manufacturers, a faltering pipeline of future blockbuster medications and a poor public image.
★ generic competition
* Moreover, many so-called “blockbuster” drugs?those with more than $1 billion in global annual sales?have had their patents, and their market share, challenged by cheaper generic rivals. Over the next five years, a record $70 billion-worth of drugs will face generic competition in America alone.
* The world's leading drugmakers face a growing threat from generic-drug manufacturers, a faltering pipeline of future blockbuster medications and a poor public image.
★ generic competition
* Moreover, many so-called “blockbuster” drugs?those with more than $1 billion in global annual sales?have had their patents, and their market share, challenged by cheaper generic rivals. Over the next five years, a record $70 billion-worth of drugs will face generic competition in America alone.